Skip to main content

Table 2 Baseline and follow-up clinical characteristics of the study population (n = 150)

From: Co-existing cerebrovascular atherosclerosis predicts subsequent vascular event: a multi-contrast cardiovascular magnetic resonance imaging study

 

Mean ± SD, or n (%)

 

Patients with vascular events (n = 41)

Patients without vascular events (n = 109)

P value

Baseline clinical characteristics

 Age, years

64.9 ± 10.4

60.6 ± 12.2

0.047

 Sex, male

28 (68.3)

81 (74.3)

0.461

 BMI, kg/m2

25.6 ± 3.3

25.5 ± 3.4

0.868

 History of smoking

24 (58.5)

67 (61.5)

0.743

 History of hypertension

28 (68.3)

79 (72.5)

0.614

 History of diabetes

7 (17.1)

35 (32.1)

0.068

 History of hyperlipidemia

16 (39.0)

59 (54.1)

0.099

 History of coronary heart disease

5 (12.2)

12 (11.0)

0.839

 History of stroke

20 (48.8)

38 (34.9)

0.119

 Systolic blood pressure, mm Hg

147.6 ± 23.2

144.7 ± 24.0

0.223

 Diastolic blood pressure, mm Hg

88.6 ± 13.5

86.6 ± 16.2

0.236

 HDL, mmol/L

1.1 ± 0.3

1.2 ± 0.6

0.374

 LDL, mmol/L

2.5 ± 1.4

2.9 ± 1.4

0.096

 Total cholesterol, mmol/L

4.2 ± 1.3

4.4 ± 1.2

0.398

 Triglycerides, mmol/L

1.7 ± 1.4

1.7 ± 1.0

0.646

 NIHSS score

5.6 ± 4.3

3.3 ± 3.0

0.003

Drug treatment during follow-up

 Antihypertension

17 (41.5)

49 (45.0)

1.000

 Lipid-lowering

33 (80.5)

86 (78.9)

0.203

 Anticoagulation

22 (53.7)

63 (57.8)

0.064

 Antiplatelet

21 (51.2)

39 (35.8)

0.368

  1. BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, NIHSS National Institutes of Health Stroke Scale